Skip to main content

Advertisement

SpringerLink
Log in

Commentary on the EULAR recommendations for the management of fibromyalgia

  • Guidelines Summary
  • Published:

From Nature Clinical Practice Rheumatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Carville SF et al. (2008) EULAR evidence based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67: 536–541

    Article  CAS  Google Scholar 

  2. O'Malley PG et al. (2000) Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 15: 659–666

    Article  CAS  Google Scholar 

  3. Fishbain D (2000) Evidence-based data on pain relief with antidepressants. Ann Med 32: 305–316

    Article  CAS  Google Scholar 

  4. Lautenbacher S and Rollman GB (1997) Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13: 189–196

    Article  CAS  Google Scholar 

  5. Kosek E and Hansson P (1997) Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70: 41–51

    Article  CAS  Google Scholar 

  6. Wood PB et al. (2007) Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25: 3576–3582

    Article  Google Scholar 

  7. Sarchielli P et al. (2007) Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 11: 343–351

    Article  Google Scholar 

  8. Skrabek RQ et al. (2008) Nabilone for the treatment of pain in fibromyalgia. J Pain 9: 164–173

    Article  CAS  Google Scholar 

  9. Baraniuk JN et al. (2004) Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 5: 48

    Article  Google Scholar 

  10. Harris RE et al. (2007) Decreased central µ-opioid receptor availability in fibromyalgia. J Neurosci 27: 10000–10006

    Article  CAS  Google Scholar 

  11. Moldofsky H et al. (1975) Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 37: 341–351

    Article  CAS  Google Scholar 

  12. Gracely RH et al. (2004) Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 127: 835–843

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. 24 Frank Lloyd Wright Drive, P.O. Box 385, Ann Arbor, MI 48106, USA dclauw@med.umich.edu

Authors and Affiliations

  1. DJ Clauw is Professor of Rheumatology and Associate Dean for Clinical and Translational Research at the University of Michigan, Ann Arbor, MI, USA.,

    Daniel J Clauw

Authors
  1. Daniel J Clauw
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

DJ Clauw has acted as a consultant for Cypress, Forest, Lilly, Pfizer and Wyeth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clauw, D. Commentary on the EULAR recommendations for the management of fibromyalgia. Nat Rev Rheumatol 4, 392–393 (2008). https://doi.org/10.1038/ncprheum0840

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0840

  • Springer Nature Limited

This article is cited by

Search

Navigation